NCT06947226 A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06933524 Evaluation of Safety and Tolerability of ATB-320 in Participants With Progressive or Metastatic Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06928363 A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors. Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06926751 Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors Status RECRUITING Phase PHASE2
NCT06925685 Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product Status ENROLLING_BY_INVITATION Phase N/A
NCT06915753 Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations Status RECRUITING Phase PHASE1
NCT06892379 A Study of HS-20110 in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06885281 A Study of ZL-1310 in Participants With Selected Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06873789 A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06873555 A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06873542 A Study of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT06826313 A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06818812 A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06816992 ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC Status RECRUITING Phase PHASE1
NCT06809530 Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis Status RECRUITING Phase PHASE1/PHASE2
NCT06806046 Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06799533 A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors Status TERMINATED Phase PHASE1
NCT06783569 A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1